Ampersand Capital Partners has provided Nitinol Devices & Components with $20 million of development capital. NDC is a medical device company with expertise in nitinol technology. Ampersand is focused on the Healthcare and Industrial sectors and targets growth equity opportunities where it can be the first institutional investor.